Portage Biotech Inc's market cap is currently ―. The company's EPS TTM is $-7.872; its P/E ratio is -0.04; Portage Biotech Inc is scheduled to report earnings on July 29, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	-	-	$ -5.30M	$ -3.63M
EBITDA	-	-	-	$ -5.30M	$ -3.63M
Net Income Common Stockholders	$ -39.37M	$ -5.16M	-	$ -7.49M	$ -949.00K
Balance Sheet	-
Cash Cash Equivalents And Short Term Investments	$ 5.34M	$ 3.44M	$ 10.54M	$ 13.10M	$ 15.04M
Total Assets	$ 49.03M	$ 92.40M	$ 99.13M	$ 210.68M	$ 216.53M
Total Debt	$ 275.00K	$ 286.00K	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -5.07M	$ -3.16M	$ -10.54M	$ -13.10M	$ -15.04M
Total Liabilities	$ 17.70M	$ 25.40M	$ 23.73M	$ 42.38M	$ 38.72M
Stockholders Equity	$ 32.00M	$ 67.66M	$ 76.05M	$ 168.94M	$ 178.43M
Cash Flow	-
Free Cash Flow	$ -3.43M	-	-	$ -2.70M	$ -2.52M
Operating Cash Flow	$ -3.43M	-	-	$ -2.70M	$ -2.51M
Investing Cash Flow	-	-	-	$ 0.00	-
Financing Cash Flow	$ 5.33M	-	-	$ 770.00K	$ -3.01M

Currency in USD

Portage Biotech Inc Earnings and Revenue History

Income Statement >

Portage Biotech Inc Debt to Assets

Balance Sheet >

Portage Biotech Inc Cash Flow

Cash Flow >

Portage Biotech Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing